Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

Rockx, Barry, Kuiken, Thijs, Herfst, Sander, Bestebroer, Theo, Lamers, Mart M., Oude Munnink, Bas B., de Meulder, Dennis, van Amerongen, Geert +16 more·2020·Science
DOI 10.1126/science.abb7314

Cited by (878)

Items 301–400 of 878

  1. Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
    Matthew D. Hall, James Melvin Anderson, Annaliesa S. Anderson, David A. Baker, James E. Bradner, Kyle R. Brimacombe, Elizabeth A. Campbell, Kizzmekia S. Corbett, Kara L. Carter, Sara R. Cherry et al. · 2021 · The Journal of Infectious Diseases
  2. Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy
    Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi · 2023 · Future Virology
  3. Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2–Infected Macaques
    Bon‐Sang Koo, Hanseul Oh, Green Kim, Eun-Ha Hwang, Hoyin Jung, Youngjeon Lee, Philyong Kang, Jae‐Hak Park, Choong‐Min Ryu, Jung Joo Hong · 2020 · The Journal of Infectious Diseases
  4. Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia
    Stefano Busani, Lorenzo Dall’Ara, Roberto Tonelli, Enrico Maria Clini, Elena Munari, Sophie Venturelli, Marianna Meschiari, Giovanni Guaraldi, Andrea Cossarizza, Vito Marco Ranieri et al. · 2020 · Therapeutic Advances in Respiratory Disease
  5. Pneumolysis and “Silent Hypoxemia” in COVID-19
    Gustavo Rafael Zubieta-Calleja, Natalia Zubieta-DeUrioste · 2020 · Indian Journal of Clinical Biochemistry
  6. Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques
    Hirohito Ishigaki, Misako Nakayama, Yoshinori Kitagawa, Cong Thanh Nguyen, Kaori Hayashi, Masanori Shiohara, Bin Gotoh, Yasushi Itoh · 2020 · Virology
  7. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins
    Kim M. Bouwman, Ilhan Tomris, Hannah L. Turner, Roosmarijn van der Woude, Tatiana M. Shamorkina, Gerlof P. Bosman, Barry Rockx, Sander Herfst, Joost Snijder, Bart L. Haagmans et al. · 2021 · PLoS Pathogens
  8. Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives
    Sara Chiappalupi, Laura Salvadori, Aleksandra Vukašinović, Rosario Donato, Guglielmo Sorci, Francesca Riuzzi · 2021 · Life Sciences
  9. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection
    Sumit Mukherjee, Bodhisattwa Banerjee, David Karasik, Milana Frenkel‐Morgenstern · 2021 · Viruses
  10. How the COVID-19 pandemic highlights the necessity of animal research
    Lisa Genzel, Roger A.H. Adan, Anton J. M. Berns, Jeroen J.J.P. van den Beucken, Arjan Blokland, Erik Boddeke, Willy M J M Bogers, Ronald E. Bontrop, Roos Bulthuis, Teun Bousema et al. · 2020 · Current Biology
  11. Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2
    I. Sanclemente-Alamán, L. Moreno-Jiménez, M. S. Benito-Martín, A. Canales-Aguirre, J. Matias-Guiu, J. Matías-Guíu, U. Gómez-Pinedo · 2020 · Frontiers in Immunology
  12. SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock
    Andrew S. Johnson, Rouholah Fatemi, William Winlow · 2020 · Frontiers in Cardiovascular Medicine
  13. Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review
    Salleh N. Ehaideb, Mashan L. Abdullah, Bisher Abuyassin, Abderrezak Bouchama · 2020 · Critical Care
  14. Genetically modified mouse models to help fight COVID-19
    Channabasavaiah B. Gurumurthy, Rolen M. Quadros, Guy Peel Richardson, Larisa Y. Poluektova, Suzanne L. Mansour, Masato Ohtsuka · 2020 · Nature Protocols
  15. Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera
    Kruglova, Natalia, Siniavin, Andrei, Gushchin, Vladimir, Mazurov, Dmitriy · 2021 · Viruses
  16. Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
    Helena Meyer‐Berg, Lucia Zhou-Yang, María Pilar de Lucas, Alberto Zambrano, Stephen C. Hyde, Deborah R. Gill · 2020 · Stem Cell Research & Therapy
  17. Low level of plasminogen increases risk for mortality in COVID-19 patients
    David Della‐Morte, Francesca Pacifici, Camillo Ricordi, Renato Massoud, Valentina Rovella, Stefania Proietti, Mariannina Iozzo, Davide Lauro, Sergio Bernardini, Stefano Bonassi et al. · 2021 · Cell Death and Disease
  18. Consensus Receptor-Binding Domain-Targeted Aptamer Selection and Designing of a Photonic Crystal-Decorated Aptasensor for SARS-CoV-2
    Ghulam Murtaza, Aysha Sarfraz Rizvi, Min Xue, Lili Qiu, Zihui Meng · 2022 · Analytical Chemistry
  19. An overview of key potential therapeutic strategies for combat in the COVID-19 battle
    Gaurav Das, Surojit Ghosh, Shubham Garg, Satyajit Ghosh, Aniket Jana, Ramkamal Samat, Nabanita Mukherjee, Rajsekhar Roy, Surajit Ghosh · 2020 · RSC Advances
  20. Reverse Zoonosis of COVID-19: Lessons From the 2009 Influenza Pandemic
    Syriam Sooksawasdi Na Ayudhya, Thijs Kuiken · 2020 · Veterinary Pathology
  21. TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques
    Amit A. Upadhyay, Elise G. Viox, T. Hoang, Arun K. Boddapati, Maria Pino, M. Lee, Jacqueline Corry, Z. Strongin, David A. Cowan, Elizabeth N. Beagle et al. · 2023 · Nature Communications
  22. Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is partially independent on hACE2 expression
    Mariano Carossino, Paige Montanaro, Aoife Kateri O’Connell, Devin Kenney, Hans P. Gertje, Kyle A. Grosz, Maria Ericsson, Bertrand R. Huber, Susanna A. Kurnick, Saravanan Subramaniam et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2
    Priti Tagde, Sandeep Tagde, Pooja Tagde, Tanima Bhattacharya, Shams Monzur, Md. Habibur Rahman, Pavel Otřísal, Tapan Behl, Syed Shams ul Hassan, Mohamed M. Abdel‐Daim et al. · 2021 · Biomedicines
  24. Epithelial stem cells and niches in lung alveolar regeneration and diseases
    Jilei Zhang, Yuru Liu · 2024 · Chinese Medical Journal - Pulmonary and Critical Care Medicine
  25. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an in vivo hACE2 transfection mouse model
    Yan Liang, 中国医学科学院医学生物学研究所，云南 昆明650118，中国, Heng Li, Jing Li, Ze-Ning Yang, Jia-Li Li, Hui-Wen Zheng, Yan-Li Chen, Hai-Jing Shi, Lei Guo et al. · 2020 · 动物学研究
  26. A Comprehensive Summary of the Knowledge on COVID-19 Treatment
    Yu Peng, Hongxun Tao, Senthil Kumaran Satyanarayanan, Kunlin Jin, Huanxing Su · 2021 · Aging and Disease
  27. Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
    Carmen W.E. Embregts, Babs E. Verstrepen, Jan A. M. Langermans, Kinga P. Böszörményi, Reina S. Sikkema, Rory D. de Vries, Donata Hoffmann, Kerstin Wernike, Lidwien A.M. Smit, Shan Zhao et al. · 2021 · One Health
  28. Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues
    Christine E. Nelson, S. Namasivayam, Taylor W. Foreman, Keith D. Kauffman, Shunsuke Sakai, Danielle E. Dorosky, N. Lora, Kelsie Brooks, E. L. Potter, N. Garza et al. · 2022 · bioRxiv
  29. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models
    Haengdueng Jeong, Youn Woo Lee, In Ho Park, Hyuna Noh, Sunghee Kim, Jiseon Kim, Donghun Jeon, Hui Jeong Jang, Jooyeon Oh, Dain On et al. · 2022 · Disease Models & Mechanisms
  30. SARS-CoV-2 vaccine candidates in rapid development
    Li-Feng Li, Pengbo Guo, Xiaoman Zhang, Zhi-Dan Yu, Wan-Cun Zhang, Hui-Qing Sun · 2020 · Human Vaccines & Immunotherapeutics
  31. 2020 update on human coronaviruses: One health, one world
    Xinbin Zhao, Yuecheng Ding, Jing Du, Yubo Fan · 2020 · Medicine in Novel Technology and Devices
  32. Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation
    Isabelle Amigues, Alexander H. Pearlman, Aarat M. Patel, Pankti D. Reid, Philip Cameron Robinson, Rashmi R. Sinha, Alfred H.J. Kim, Taryn Youngstein, Arundathi Jayatilleke, Maximilian F. Konig · 2020 · Expert Review of Clinical Immunology
  33. Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment
    Jun‐yi Zhu, Jin‐Gu Lee, Joyce van de Leemput, Hangnoh Lee, Zhe Han · 2021 · Cell & Bioscience
  34. Bronchial epithelia from adults and children: SARS-CoV-2 spread via syncytia formation and type III interferon infectivity restriction
    Guillaume Beucher, Marie-Lise Blondot, Alexis Celle, Noémie Pied, Patrícia Recordon-Pinson, Pauline Estèves, Muriel Faure, Mathieu Métifiot, Sabrina Lacomme, Denis Dacheux et al. · 2022 · Proceedings of the National Academy of Sciences
  35. A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2
    Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, Wen‐Jiun Peng, Juin-Hua Huang, Be-Sheng Kuo, Lin Feng, Yaw-Jen Liu, Zhi Liu, Huang-Ting Wu et al. · 2022 · Emerging Microbes & Infections
  36. COVID‐19 vaccines: Knowing the unknown
    Huibin Lv, Nicholas C. Wu, Chris Ka Pun Mok · 2020 · European Journal of Immunology
  37. Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC)
    Colin Pawlowski, Tyler E. Wagner, Arjun Puranik, Karthik Murugadoss, Liam Loscalzo, AJ Venkatakrishnan, Rajiv K. Pruthi, Damon Eugene Houghton, John Charles O’Horo, William George Morice et al. · 2020 · eLife
  38. Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective
    Yulong Wei, P. Aris, Heba Farookhi, X. Xia · 2021 · Scientific Reports
  39. Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital
    Nicola Clementi, Roberto Ferrarese, Marco Tonelli, Virginia Amato, Sara Racca, Massimo Locatelli, Giuseppe Lippi, Guido Silvestri, Massimo Clementi, Nicasio Mancini · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
  40. SARS‐CoV‐2: Mechanism of infection and emerging technologies for future prospects
    Shiqin Li, Sijia Li, Cyrollah Disoma, Rong Zheng, Mei Ling Zhou, Aroona Razzaq, Pinjia Liu, Yuzheng Zhou, Zijun Dong, Ashuai Du et al. · 2020 · Reviews in Medical Virology
  41. Interferon gamma in the treatment of patients with moderate COVID-19
    A. L. Myasnikov, Svetlana A. Berns, P. A. Talyzin, Ershov Fi · 2021 · Problems of Virology
  42. COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns
    Mohamed Joma, Claire-Maëlle Fovet, Nabila Seddiki, Pierre Gressèns, Mireille Laforge · 2021 · Vaccines
  43. Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization
    Alexandru Adrian Hennrich, Bevan Sawatsky, Rosalía Santos-Mandujano, Dominic H. Banda, Martina Oberhuber, Anika Schopf, Verena Pfaffinger, Kevin Wittwer, Christiane Riedel, Christian Karl Pfaller et al. · 2021 · PLoS Pathogens
  44. Rapid Development of Analytical Methods for Evaluating Pandemic Vaccines: A Covid-19 Perspective
    Jeremy Baldwin, Sakshi Piplani, Isaac G. Sakala, Yoshikazu Honda‐Okubo, Lei Li, Nikolai Petrovsky · 2021 · Bioanalysis
  45. Experimental Models of SARS-CoV-2 Infection: Possible Platforms to Study COVID-19 Pathogenesis and Potential Treatments
    Sareh Pandamooz, Benjamin Jurek, Carl-Philipp Meinung, Zahra Baharvand, Alireza Sahebi Shahem-abadi, Silke Haerteis, Jaleel A. Miyan, James R. Downing, Mehdi Dianatpour, Afshin Borhani‐Haghighi et al. · 2021 · The Annual Review of Pharmacology and Toxicology
  46. Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens
    Fabian Z. X. Lean, Mart Matthias Lamers, Samuel Pattillo Smith, Rebecca Shipley, Debby Schipper, Nigel James Temperton, Bart L. Haagmans, Ashley C. Banyard, Kevin R. Bewley, Miles W. Carroll et al. · 2020 · Scientific Reports
  47. Delta-range coupling between prefrontal cortex and hippocampus supported by respiratory rhythmic input from the olfactory bulb in freely behaving rats
    Rola Mofleh, Bernát Kocsis · 2021 · Scientific Reports
  48. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate
    D. Patel, C. Field, K. M. Septer, D. Sim, Matthew J. Jones, T. Heinly, T. Vanderford, E. McGraw, T. Sutton · 2021 · Journal of Virology
  49. Inefficient Placental Virus Replication and Absence of Neonatal Cell-Specific Immunity Upon Sars-CoV-2 Infection During Pregnancy
    Ann‐Christin Tallarek, Christopher Urbschat, Luís Fonseca Brito, Stephanie Stanelle‐Bertram, Susanne Krasemann, Giada Frascaroli, Kristin Thiele, Agnes Wieczorek, Nadine Felber, Marc Lütgehetmann et al. · 2021 · Frontiers in Immunology
  50. Alternative experimental approaches to reduce animal use in biomedical studies
    Seung Yun Lee, Da Young Lee, Ji Hyeop Kang, Jae Won Jeong, Jae Hyeon Kim, Hyun Woo Kim, Dong Hoon Oh, Jun‐Mo Kim, Shin‐Jae Rhim, Gap‐Don Kim et al. · 2022 · Journal of Drug Delivery Science and Technology
  51. Evolutionary rate of SARS-CoV-2 increases during zoonotic infection of farmed mink
    Ashleigh F. Porter, Damian F. J. Purcell, Benjamin P. Howden, Sebastián Duchêne · 2023 · Virus Evolution
  52. Host range of SARS-CoV-2 and implications for public health
    Joanne M. Santini, Sarah Edwards · 2020 · The Lancet Microbe
  53. SARS-CoV-2 viability under different meteorological conditions, surfaces, fluids and transmission between animals
    María Fernández‐Raga, Laura Díaz-Marugán, Marta García Escolano, Carlos Bort, Víctor Fanjul · 2020 · Environmental Research
  54. Recent advances in antibody‐based immunotherapy strategies for COVID‐19
    Abdolreza Esmaeilzadeh, Samaneh Miri Rostami, Pegah Moharrami Yeganeh, Safa Tahmasebi, Majid Ahmadi · 2021 · Journal of Cellular Biochemistry
  55. Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
    Petra Mooij, Juan García‐Arriaza, Patricia Pérez, Adrián Lázaro-Frías, Babs E. Verstrepen, Kinga P. Böszörményi, Daniëlla Mortier, Zahra C. Fagrouch, Gwendoline Kiemenyi-Kayere, Henk Niphuis et al. · 2022 · Frontiers in Immunology
  56. Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence
    Anna Riccio, Silvia Santopolo, Antonio Rossi, Sara Piacentini, Jean‐François Rossignol, M. Gabriella Santoro · 2022 · Cellular and Molecular Life Sciences
  57. Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques
    Emily E. Speranza, Jyothi N. Purushotham, Julia Rebecca Port, Benjamin H. Schwarz, Meaghan Flagg, Brandi N. Williamson, Friederike Feldmann, Manmeet Singh, Lizzette Pérez-Pérez, Gail L. Sturdevant et al. · 2022 · Life Science Alliance
  58. Assessing the SARS-CoV-2 threat to wildlife: Potential risk to a broad range of mammals
    Fernando Martínez‐Hernández, Ana Belem Isaak-Delgado, Jorge Alberto Alfonso-Toledo, Claudia Irais Muñoz-García, Guiehdani Villalobos, Nidia Aréchiga-Ceballos, Emilio Rendón‐Franco · 2020 · Perspectives in Ecology and Conservation
  59. Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
    Faheem Hyder Pottoo, Tareq Abu‐Izneid, Abdallah Mohammad Ibrahim, Md. Noushad Javed, Noora Alhajri, Amar Hamrouni · 2021 · Saudi Pharmaceutical Journal
  60. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection
    Zhen Jian Huang, Bo Ning, He S. Yang, Brady M. Youngquist, Alex Niu, Christopher J. Lyon, Brandon J. Beddingfield, Alyssa C. Fears, Chandler H. Monk, Amelie E. Murrell et al. · 2021 · Journal of Clinical Investigation
  61. Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
    Asim Z. Abbasi, Dania A. Kiyani, Syeda M. Hamid, Muhammad Saalim, Ammad Fahim, Nasir Jalal · 2021 · Journal of Medical Virology
  62. Government Intervention Measures Effectively Control COVID-19 Epidemic in Wuhan, China
    Xing Xin, Shu-fang Li, Ling Jie Cheng, Changyu Liu, Yin-juan Xin, Hailong Huang, Rajluxmee Beejadhursing, Shaoshuai Wang, Ling Feng · 2021 · Current Medical Science
  63. Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions
    Marcel Renn, Eva Bartok, Thomas Zillinger, Gunther Hartmann, Rayk Behrendt · 2021 · Pharmacology & Therapeutics
  64. COVID-19 Research: Lessons from Non-Human Primate Models
    Laure Albrecht, Elodie Bishop, Basile Jay, Blaise Lafoux, Marie Minoves, Caroline Passaes · 2021 · Vaccines
  65. SARS‐CoV‐2 cellular tropism and direct multiorgan failure in COVID‐19 patients: Bioinformatic predictions, experimental observations, and open questions
    Anna A. Valyaeva, Anastasia A. Zharikova, Eugene V. Sheval · 2022 · Cell Biology International
  66. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
    Nina Reuter, Xiaohan Chen, Barbara Kropff, Antonia Sophia Peter, William J. Britt, Michael Mach, Klaus Überla, Marco Thomas · 2023 · Viruses
  67. Single-cell atlas of a non-human primate reveals new pathogenic mechanisms of COVID-19
    Lei Han, Xiaoyu Wei, Chuanyu Liu, Giacomo Volpe, Zhifeng Wang, Taotao Pan, Yue Yuan, Ying Lei, Yiwei Lai, Carl Ward et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  68. Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020
    C. Manickam, S. Sugawara, R. K. Reeves · 2020 · PLoS Pathogens
  69. Current advances in the detection of COVID-19 and evaluation of the humoral response
    María Ana Huergo, Nguyễn Thị Kim Thanh · 2020 · The Analyst
  70. Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19
    Cheng‐Pu Sun, Jia‐Tsrong Jan, I-Hsuan Wang, Hsiu‐Hua Ma, Hui‐Ying Ko, Ping‐Yi Wu, Tzu-Jiun Kuo, Hsin-Ni Liao, Yu-Hua Lan, Zong‐Lin Sie et al. · 2021 · PLoS Pathogens
  71. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors
    Jorge Fabián Quarleri, M. Victoria Delpino · 2021 · Cytokine & Growth Factor Reviews
  72. Hydroxychloroquine in the treatment and prophylaxis of SARS-CoV-2 infection in non- human primates
    Pauline Maisonnasse, Jérémie Guedj, Vanessa Contreras, Sylvie Behillil, Caroline Solas, Romain Marlin, Thibaut Naninck, Andrés Pizzorno, Julien Lemaître, António Gonçalves et al. · 2020
  73. Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection
    Sreelekshmy Mohandas, Rajlaxmi Jain, Pragya Dhruv Yadav, Anita Shete-Aich, Prasad Sarkale, Manoj Kadam, Abhimanyu Kumar, Gururaj Rao Deshpande, Shreekant Baradkar, Savita Patil et al. · 2020 · The Indian Journal of Medical Research
  74. Severe acute respiratory syndrome coronavirus‐2 natural animal reservoirs and experimental models: systematic review
    Salma N. Younes, N. Younes, F. Shurrab, Gheyath K Nasrallah · 2020 · Reviews in Medical Virology
  75. Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
    Robert W. Cross, Abhishek N. Prasad, Viktoriya Borisevich, Courtney B. Woolsey, Krystle N. Agans, Daniel J. Deer, Natalie S. Dobias, Joan B. Geisbert, Karla A. Fenton, Thomas W. Geisbert · 2021 · Cell Reports
  76. Nonhuman primate models for SARS-CoV-2 research: Consider alternatives to macaques
    Michael Chang, Sheri Ann Hild, Franziska B. Grieder · 2021 · Lab Animal
  77. Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis
    Caroline J. Zeiss, Susan R Compton, Rebecca T. Veenhuis · 2021 · ILAR Journal
  78. The Mechanisms and Animal Models of SARS-CoV-2 Infection
    Wenrui Jia, Juan Wang, Bao Sun, Jiecan Zhou, Yamin Shi, Zheng Zhou · 2021 · Frontiers in Cell and Developmental Biology
  79. Hypoxia may be a determinative factor in COVID-19 progression
    Paweł Grieb, Maciej Świątkiewicz, Katarzyna Prus, Konrad Rejdak · 2021 · Current Research in Pharmacology and Drug Discovery
  80. Overview of Nonhuman Primate Models of SARS-CoV-2.
    A. Trichel · 2021 · Comparative medicine
  81. COVID-19: what the clinician should know about post-mortem findings
    Danny David Jonigk, Bruno Märkl, Julie Helms · 2020 · Intensive Care Medicine
  82. Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell–cell fusion
    Nazia Thakur, Carina Conceicao, Ariel Isaacs, Stacey Human, Naphak Modhiran, Rebecca K. McLean, Miriam Pedrera, Tiong Kit Tan, Pramila Rijal, Alain Townsend et al. · 2020 · Journal of General Virology
  83. Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
    Ahmed O. Shalash, Waleed M. Hussein, Mariusz Skwarczyński, István Tóth · 2021 · Advanced Science
  84. UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates
    Kyle Rosenke, Friederike Feldmann, Atsushi Okumura, Frederick Hansen, Tsing-Lee Tang-Huau, Kimberly D. Meade-White, Benjamin Kaza, Julie A. Callison, Matthew C. Lewis, Brian J. Smith et al. · 2021 · Emerging Microbes & Infections
  85. SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
    Pooja Shivshankar, Harry Karmouty‐Quintana, Tingting Mills, Marie–Françoise Doursout, Yanyu Wang, Agnieszka K. Czopik, Scott E. Evans, Holger K. Eltzschig, Xiaoyi Yuan · 2022 · Inflammation
  86. 3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics
    Roberto Plebani, Haiqing Bai, Longlong Si, Jing Li, Chunhe Zhang, Mario Romano · 2022 · International Journal of Molecular Sciences
  87. After the virus has cleared—Can preclinical models be employed for Long COVID research?
    Ethan B. Jansen, S. N. Orvold, C. Swan, Anthony Yourkowski, Brittany Thivierge, Magen E. Francis, Anni Ge, Melissa L. Rioux, Joseph Darbellay, J. Howland et al. · 2022 · PLoS Pathogens
  88. Neuropathies and neurological dysfunction induced by coronaviruses
    Mina Gholami, Sepideh Safari, Luis Ulloa, Majid Motaghinejad · 2021 · Journal of NeuroVirology
  89. The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector
    Tetiana A. Zaichuk, Yury D. Nechipurenko, A. A. Adzhubey, С. Б. Оникиенко, В. А. Черешнев, Sergei S. Zainutdinov, Galina V. Kochneva, Netesov Sv, Olga V. Matveeva · 2020 · Molecular Biology
  90. Dual-Fluorescence Labeling Pseudovirus for Real-Time Imaging of Single SARS-CoV-2 Entry in Respiratory Epithelial Cells
    Yingxin Ma, Guobin Mao, Guoqiang Wu, Minghai Chen, Fujun Qin, Luping Zheng, Xian‐En Zhang · 2021 · ACS Applied Materials & Interfaces
  91. SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
    Govindasamy Kanimozhi, Pradhapsingh Bharathiraja, Charan Singh Pawar, Haseeb Ahmad Khan, Salman Alrokayan, Nagarajan Rajendra Prasad · 2021 · Frontiers in Pharmacology
  92. A Multidisciplinary Approach to Coronavirus Disease (COVID-19)
    Aliye Gediz Ertürk, Arzu Şahin, Ebru Batı Ay, Emel Pelit, Emine Bağdatlı, Irem Kulu, Melek Gül, Seda Mesci̇, Serpil Eryılmaz, Sirin Oba Ilter et al. · 2021 · Molecules
  93. Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models
    S. Choudhary, Isis Kanevsky, S. Yıldız, R. Sellers, K. Swanson, Tania Franks, Raveen Rathnasinghe, Raquel Muñoz-Moreno, S. Jangra, O. Gonzalez et al. · 2022 · Toxicologic pathology (Print)
  94. Lipid and Nucleocapsid N-Protein Accumulation in COVID-19 Patient Lung and Infected Cells
    Anita E. Grootemaat, Sanne van der Niet, Edwin R. Scholl, Eva Roos, Bernadette Schurink, Marianna Bugiani, Sara Miller, Per W. B. Larsen, Jeannette E. Pankras, Eric A. Reits et al. · 2022 · Microbiology Spectrum
  95. Engineering Mice to Study Human Immunity
    Esen Sefik, Tianli Xiao, Michael Chiorazzi, Ian D. Odell, Fengrui Zhang, Kriti Agrawal, Goran Micevic, Richard Anthony Flavell · 2025 · Annual Review of Immunology
  96. An integrative look at SARS‑CoV‑2 (Review)
    Miguel Angel Ortega, Oscar Fraile‐Μartinez, Cielo García Montero, Sandra García‐Gallego, Lara Sánchez‐Trujillo, Diego Torres‐Carranza, Miguel Ángel Álvarez-Mon, Leonel Pekarek, Natalio García‐Honduvilla, Julia Buján et al. · 2020 · International Journal of Molecular Medicine
  97. Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates
    M. Stammes, J. Lee, L. Meijer, Thibaut Naninck, L. Doyle-Meyers, Alexander G. White, H. Borish, A. Hartman, X. Alvarez, Shashank R. Ganatra et al. · 2021 · Trends in Molecular Medicine
  98. Mouse models in COVID-19 research: analyzing the adaptive immune response
    S. Clever, A. Volz · 2022 · Medical Microbiology and Immmunology
  99. Cell and Animal Models for SARS-CoV-2 Research
    Eloïne Bestion, P. Halfon, S. Mezouar, J. Mege · 2022 · Viruses
  100. Analysis of the Chemical and Physical Environmental Aspects that Promoted the Spread of SARS-CoV-2 in the Lombard Area
    Roberto Dragone, Giorgio Licciardi, Gerardo Grasso, Costantino Del Gaudio, Jocelyn Chanussot · 2021 · International Journal of Environmental Research and Public Health